May 02, 2017 11:01 am UTC| Business
BOSTON, May 02, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that an investigator-initiated Investigational New Drug (IND) application to the...
May 02, 2017 11:01 am UTC| Business
BOSTON, May 02, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that an investigator-initiated Investigational New Drug (IND) application to the...
May 02, 2017 11:01 am UTC| Business
Conference Call and WebcastToday, May 2, 2017 at 10:00 a.m. ET719/325-4767, conference ID 6898633 or www.bbgi.com Replay information provided below NAPLES, Fla., May 02, 2017 -- Beasley Broadcast Group, Inc....
May 02, 2017 11:01 am UTC| Business
Conference Call and WebcastToday, May 2, 2017 at 10:00 a.m. ET719/325-4767, conference ID 6898633 or www.bbgi.com Replay information provided below NAPLES, Fla., May 02, 2017 -- Beasley Broadcast Group, Inc....
May 02, 2017 11:01 am UTC| Business
NEW YORK, May 02, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced today the issuance of...
May 02, 2017 11:01 am UTC| Business
NEW YORK, May 02, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced today the issuance of...
Rita M. O’Connor Appointed Chief Financial Officer of PLx Pharma
May 02, 2017 11:00 am UTC| Business
HOUSTON, May 02, 2017 -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81...